ENLV

Enlivex Ltd.

Nasdaq· Pharmaceutical Preparations· Inc. L3· CIK 0001596812 Biotech & Drug Discovery

$2.70 +0.14 (+5.27%)

Oct 27 4:00 PM ET · prev $2.56

Market cap

$3.5M

Nano cap

Consensus

Buy

86% Buy or better · 7 analysts

Median target

🔒 Subscribers only

Next earnings

Nov 12

in 16 days

1 year

−99.0%

from $259.20 · Oct 28

30 days

−67.2%

from $8.22

52-week range

$2.56–290.40

−99% from high · low Oct 26

Avg volume 20D

158.1K

Oct 8 spike 2.04M

Short interest

159.3K

≈0.8% of shares · +61.6%

Days to cover

1.0

at average volume

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read BEARISH 9 reports · 90 days

Balance 3 bearish · 2 bullish · 4 neutral oldest → newest, height = score

Avg score

·High conf. 7/9 ·Next Earnings date, Nov 12, 2026

Strongest BEARISH Enlivex announced a cost reduction plan on October 19, 2026, including a ~60% workforce reduction, wind-down…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

R Jul 28 Enlivex announced a $400M private placement of ordinary shares at a…
X Sep 15 Short interest falls 59.8% to 48.2K
R Sep 22 Enlivex terminated its securities purchase agreement with the Rain F…
X Sep 30 Short interest jumps 104.5% to 98.6K
X Oct 15 Short interest jumps 61.6% to 159.3K
E Oct 19 FDA: Enlivex Announces Cost Reduction Plan to Focus Resources o…
R Oct 19 Enlivex announced a cost reduction plan on October 19, 2026, includi…
R Oct 19 Enlivex announced a cost reduction plan to wind down non-clinical R&…

Signal stack

Where each data set points today.

InstitutionsMIXED

Q2 2026: 6 added (0 new), 4 trimmed or exited.
AnalystsBULLISH

6 of 7 rate it Buy or better.
Short sellersBUILDING

Short interest +61.6% to 159.3K shares. 1.0 days to cover, ≈0.8% of shares.
TrendDOWNTREND

77% below its 50-day average. New closing low $2.56 on Oct 26.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
ARK Investment Management LLC	DOUBLED	2,382,731	$1.3M
BANK OF AMERICA CORP /DE/	ADD	193,150	$106.0K
SUSQUEHANNA INTERNATIONAL GROUP, LLP	DOUBLED	157,648	$86.7K
GEODE CAPITAL MANAGEMENT, LLC	ADD	129,858	$71.4K
SIMPLEX TRADING, LLC	DOUBLED	111,406	$61.3K
UBS Group AG	TRIM	73,909	$40.6K
MORGAN STANLEY	NEAR_EXIT	8,497	$4.7K
GROUP ONE TRADING LLC	DOUBLED	1,042	$573.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

7 analysts

Buy 86% rate it Buy or better

Strong Buy2Buy4Hold1Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access

Recent actions

Date	Firm	Action	Rating
Aug 3, 2026	HC Wainwright & Co. MAINTAIN	MAINTAIN	Buy

Earnings setup

Estimates

Nov 12

reports in 16 days

Revision history: 🔒 Fresh data, subscribers only

Period	EPS est.	Range	30D rev.	Revenue
Current Q	🔒 Fresh data, subscribers only
Next Q	🔒 Fresh data, subscribers only
Current FY	🔒 Fresh data, subscribers only
Next FY	🔒 Fresh data, subscribers only